STIPE THERAPEUTICS
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway; a major driver of innate immunity, and regulator of tumorigenesis and autoimmune disorders. The company has identified and validated compounds that sensitizes the STING pathway and by this modulates the tumor microenvironment to support a potent anti-tumoral response.
STIPE THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Aarhus, Midtjylland, Denmark
Country:
Denmark
Website Url:
http://www.stipetherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
20 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon LetsEncrypt SSL By Default Microsoft Exchange Online Office 365 Mail
Similar Organizations
Achilles Therapeutics
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Domain Therapeutics
Domain Therapeutics develops small molecules targeting G-coupled protein receptors.
Evernow
Evernow is a provider of women's health care services before, during, and after menopause.
INmuneBIO
INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Memo Therapeutics
Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.
Newcells Biotech
Newcells Biotech are experts in the production of induced pluripotent stem cells.
Pathios Therapeutics
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Advisors List
Board_member
2019-01-01
Current Employees Featured
Christian Schetter Executive Chairman @ STipe Therapeutics
Executive Chairman
2019-09-01
Richard Sainson Chief Scientific Officer @ STipe Therapeutics
Chief Scientific Officer
2022-06-01
Claus Elsborg Olesen Co-Founder & Chief Executive Officer @ STipe Therapeutics
Co-Founder & Chief Executive Officer
2018-01-01
Founder
Investors List
Life Science Venture Capital Management
Life Science Venture Capital Management investment in Series A - STipe Therapeutics
Wellington Partners
Wellington Partners investment in Series A - STipe Therapeutics
Novo Holdings
Novo Holdings investment in Series A - STipe Therapeutics
Arix Bioscience
Arix Bioscience investment in Series A - STipe Therapeutics
Sunstone LSV General Partner
Sunstone LSV General Partner investment in Series A - STipe Therapeutics
BioInnovation Institute
BioInnovation Institute investment in Convertible Note - STipe Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-31 | STipe Therapeutics appoints Dr Richard Sainson as Chief Scientific Officer to Lead Research and Discovery |
Official Site Inspections
http://www.stipetherapeutics.com
- Host name: web81.123hotel.dk
- IP address: 94.231.109.72
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "STipe Therapeutics"
STipe Therapeutics
About STipe Therapeutics. STipe Therapeutics is a privately held biotechnology company with a vision to become a leader in the immune-oncology field, pioneer therapies using a novel …See details»
STipe Therapeutics
STipe Therapeutics . STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein …See details»
Stipe Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions …See details»
STipe Therapeutics - Crunchbase Company Profile
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular …See details»
STipe Therapeutics (DK) - Life-Sciences-Europe.com
Jan 1, 2018 https://www.stipetherapeutics.com STipe Therapeutics is a privately held biotechnology company with a vision to become a leader in the immune-oncology field, …See details»
STipe Therapeutics
Nov 5, 2024 Aarhus University. Nordre Ringgade 1 8000 Aarhus E-mail: au@au.dk Tel: +45 8715 0000. CVR no: 31119103 EORI no: DK-31119103See details»
STipe Therapeutics
Investors. STipe Therapeutics is supported by four investors | follow the links below to learn more about themSee details»
STipe Therapeutics | DANISH BIO – DANSK BIOTEK
Col@stipetherapeutics.com Telephone: +45 61260035. Web: stipetherapeutics.com Established: 2018. Number of employees: 18. Print Go Back. At Dansk Biotek we use cookies for analytical purposes only. To read …See details»
STipe Therapeutics - VentureRadar
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting... ... Find out more ...See details»
Working at STipe Therapeutics - Glassdoor
See what employees say it's like to work at STipe Therapeutics. Salaries, reviews, and more - all posted by employees working at STipe Therapeutics.See details»
STipe Therapeutics - Overview, News & Similar companies
STipe Therapeutics appoints Dr Richard Sainson as Chief Scientific Officer to Lead Research and Discovery AARHUS, Denmark, May 31, 2022 (GLOBE NEWSWIRE) -- STipe Therapeutics …See details»
STipe Therapeutics - Craft
STipe Therapeutics has 5 employees at their 1 location and $21.87 m in total funding,. See insights on STipe Therapeutics including office locations, competitors, revenue, financials, …See details»
STipe Therapeutics - NOME
STipe Therapeutics STipe Therapeutics, an early stage biotech company develops cancer drugs that target intracellular protein-protein interactions, which are highlighted as major drivers of …See details»
STipe Therapeutics
Apr 16, 2020 Dr Bethell brings 30 years’ experience in drug discovery and development in the biopharmaceutical industry. Most recently he served as Chief Scientific Officer at Medivir AB, …See details»
Stipe Therapeutics - Sunstone
STipe Therapeutics. STipe Therapeutics A/S (Aarhus, Denmark) focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs …See details»
STipe Therapeutics - PitchBook
STipe Therapeutics General Information Description. Operator of a biopharmaceutical company designed to harness the innate immune system to battle cancer. The company offers first-in …See details»
STipe Therapeutics
Aarhus, Denmark, 30 September 2019, STipe Therapeutics (STipe), a company founded to exploit a novel approach to the stimulator of interferon genes (STING) Pathway, a major driver …See details»
STipe Therapeutics Company Information - Funding, Investors, …
Jan 1, 2019 https://stipetherapeutics.com. Platform dedicated to harnessing the innate immune system to battle cancer. GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, …See details»
STipe Therapeutics
May 15, 2020 Aarhus, Denmark, and Copenhagen, Denmark, 15 May 2020, STipe Therapeutics (STipe), a company with a novel approach to leverage the stimulator of interferon genes …See details»
STipe Therapeutics
STipe Therapeutics appoints Dr Sonia Quaratino to chair the Scientific and Clinical Advisory Board Learn moreSee details»